Selected article for: "drug development and molecular complex"

Author: Mahmud, Shafi; Uddin, Mohammad Abu Raihan; Paul, Gobindo Kumar; Shimu, Mst Sharmin Sultana; Islam, Saiful; Rahman, Ekhtiar; Islam, Ariful; Islam, Md Samiul; Promi, Maria Meha; Emran, Talha Bin; Saleh, Md Abu
Title: Virtual screening and molecular dynamics simulation study of plant-derived compounds to identify potential inhibitors of main protease from SARS-CoV-2
  • Cord-id: gf9inovy
  • Document date: 2021_2_1
  • ID: gf9inovy
    Snippet: The new coronavirus (SARS-CoV-2) halts the world economy and caused unbearable medical emergency due to high transmission rate and also no effective vaccine and drugs has been developed which brought the world pandemic situations. The main protease (M(pro)) of SARS-CoV-2 may act as an effective target for drug development due to the conservation level. Herein, we have employed a rigorous literature review pipeline to enlist 3063 compounds from more than 200 plants from the Asian region. Therefor
    Document: The new coronavirus (SARS-CoV-2) halts the world economy and caused unbearable medical emergency due to high transmission rate and also no effective vaccine and drugs has been developed which brought the world pandemic situations. The main protease (M(pro)) of SARS-CoV-2 may act as an effective target for drug development due to the conservation level. Herein, we have employed a rigorous literature review pipeline to enlist 3063 compounds from more than 200 plants from the Asian region. Therefore, the virtual screening procedure helps us to shortlist the total compounds into 19 based on their better binding energy. Moreover, the Prime MM-GBSA procedure screened the compound dataset further where curcumin, gartanin and robinetin had a score of (−59.439, −52.421 and − 47.544) kcal/mol, respectively. The top three ligands based on binding energy and MM-GBSA scores have most of the binding in the catalytic groove Cys145, His41, Met165, required for the target protein inhibition. The molecular dynamics simulation study confirms the docked complex rigidity and stability by exploring root mean square deviations, root mean square fluctuations, solvent accessible surface area, radius of gyration and hydrogen bond analysis from simulation trajectories. The post-molecular dynamics analysis also confirms the interactions of the curcumin, gartanin and robinetin in the similar binding pockets. Our computational drug designing approach may contribute to the development of drugs against SARS-CoV-2.

    Search related documents:
    Co phrase search for related documents
    • accessible surface area and active groove: 1
    • accessible surface area and active site: 1
    • accessible surface area and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • accessory protein and active site: 1, 2
    • accessory protein and activity inhibition: 1
    • accessory protein and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accurate rapid and active site: 1
    • accurate rapid and activity inhibition: 1
    • accurate rapid and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accurate screening and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • active cavity and acute respiratory syndrome: 1, 2, 3, 4
    • active point and acute respiratory syndrome: 1, 2, 3, 4
    • active region and acute respiratory syndrome: 1, 2, 3, 4
    • active region pro and acute respiratory syndrome: 1
    • active residue and acute respiratory syndrome: 1, 2, 3
    • active site and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active site bond interaction and acute respiratory syndrome: 1
    • active site residue and acute respiratory syndrome: 1, 2
    • activity inhibition and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25